Envista Holdings Corp (NVST) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$24.29
Price Target
$27.00
Target Range
$19.00 — $35.00
Analyst Rating
Hold
Forward P/E17.2x
Trailing P/E86.7x
Forward PEG11.53
Implied Growth+246.8%
Median Target$25.00
Analyst Spread59.3%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$19
-21.8%
Consensus
$27
+11.2%
Bull Case
$35
+44.1%
NVST Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Envista Holdings Corp (NVST) has a Wall Street consensus price target of $27.00, based on estimates from 19 covering analysts. With the stock currently trading at $24.29, this represents a potential upside of +11.2%. The company has a market capitalization of $4.04B.
Analyst price targets range from a low of $19.00 to a high of $35.00, representing a 59% spread in expectations. The median target of $25.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 7 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, NVST trades at a trailing P/E of 86.7x and forward P/E of 17.2x. The forward PEG ratio of 11.53 reflects a premium valuation. Analysts expect EPS to grow +246.8% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+39.8%
Avg Forward P/E54.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 XRAYDENTSPLY SIRONA Inc. | $2.2B | $10.96 | $13.40 | +22.3% | Hold | 7.7x | 31 |
 ALGNAlign Technology, Inc. | $12.1B | $168.39 | $203.60 | +20.9% | Buy | 14.9x | 33 |
 HSICHenry Schein, Inc. | $8.1B | $70.50 | $86.43 | +22.6% | Hold | 13.3x | 32 |
 MMSIMerit Medical Systems, Inc. | $3.7B | $62.33 | $95.00 | +52.4% | Buy | 15.5x | 13 |
 NVCRNovoCure Limited | $1.9B | $16.83 | $33.50 | +99.0% | Buy | — | 15 |
 OMCLOmnicell, Inc. | $2.0B | $43.33 | $57.20 | +32.0% | Hold | 22.4x | 19 |
 ITGRInteger Holdings Corporation | $3.0B | $87.92 | $98.00 | +11.5% | Buy | 13.5x | 14 |
 ATRCAtriCure, Inc. | $1.4B | $27.80 | $50.67 | +82.3% | Buy | 370.7x | 19 |
 SYKStryker Corporation | $112.7B | $294.25 | $403.69 | +37.2% | Buy | 19.6x | 50 |
 ZBHZimmer Biomet Holdings, Inc. | $16.3B | $83.37 | $97.90 | +17.4% | Hold | 9.8x | 42 |
Upside Potential Comparison
NVCRATRCMMSISYKOMCLHSICXRAYALGNSee NVST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NVST vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNVST — Frequently Asked Questions
Quick answers to the most common questions about buying NVST stock.
What is the NVST stock price target for 2026?
Envista Holdings Corp (NVST) has a consensus 12-month price target of $27, implying 11.2% upside from $24.285. The 19 analysts covering NVST see moderate appreciation potential.
Is NVST a buy, sell, or hold?
NVST has a consensus rating of "Hold" based on 19 Wall Street analysts. The rating breakdown is mixed, with 11 Hold ratings making up the largest segment. The consensus 12-month price target of $27 implies 11.2% upside from current levels.
Is NVST stock overvalued or undervalued?
With a forward P/E of 17.2112x, NVST trades at a relatively low valuation. The consensus target of $27 implies 11.2% appreciation, suggesting meaningful undervaluation.
How high can NVST stock go?
The most bullish Wall Street analyst has a price target of $35 for NVST, while the most conservative target is $19. The consensus of $27 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover NVST stock?
NVST is well covered by analysts, with 19 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 11 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the NVST stock forecast?
The 12-month NVST stock forecast based on 19 Wall Street analysts shows a consensus price target of $27, with estimates ranging from $19 (bear case) to $35 (bull case). The median consensus rating is "Hold".
What is NVST's forward P/E ratio?
NVST trades at a forward P/E ratio of 17.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 86.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy NVST stock?
Wall Street analysts are optimistic on NVST, with a "Hold" consensus rating and $27 price target (11.2% upside). 7 of 19 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do NVST price targets vary so much?
NVST analyst price targets range from $19 to $35, a 59% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $27 consensus represents the middle ground.